News

NICE recommends ticagrelor with aspirin for three years post-MI

BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4438 (Published 12 August 2016) Cite this as: BMJ 2016;354:i4438
  1. Jacqui Wise
  1. London

Patients who have had a myocardial infarction (MI) should be given a low dose of the anti-clotting drug ticagrelor (Brilique) together with aspirin for as long as three years, new draft guidance from the National Institute for Health and Care Excellence (NICE) says.1

Most centres in the United Kingdom already use a higher (90 mg) dose of ticagrelor in combination with aspirin for as long as 12 months as first line management …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe